Results of trial of venetoclax with bendamustine/rituximab or bendamustine/obinutuzumab in CLL
Stephan Stilgenbauer • 3 Dec 2016
Can we afford to have CLL patients on a therapy for the rest of their lives?
John Gribben et al. • 4 Dec 2015
Infections in patients receiving brentuximab vedotin or BTK inhibitors
Livio Pagano • 8 Mar 2021